PUBLIC PERM CASES · FY2026 Q4
Hikma Pharmaceuticals USA Inc.
13 public cases in the OFLC disclosure file. Case-level data is quarterly, not live DOL status.
Latest DOL cases (live)
The quarterly file will not contain cases decided after the quarter. Enter any known case number for this employer; we scan nearby public numbers and keep the same employer.
G-100-25325-430505
CertifiedPrincipal Scientist, Injectables Analytical Research
2025-11-21 → 2026-09-18
G-100-25325-430499
CertifiedSenior Scientist, Analytical Research & Development
2025-11-21 → 2026-09-18
G-100-25325-430498
CertifiedSenior Scientist, Analytical Research & Development
2025-11-21 → 2026-09-18
G-100-25120-923611
CertifiedAssociate Director, Injectables Formulation Development
2025-04-30 → 2026-06-08
G-100-25052-716269
CertifiedSenior Scientist, Analytical Research & Development
2025-02-21 → 2026-05-13
G-100-25052-716254
CertifiedSenior Scientist, Analytical Research & Development
2025-02-21 → 2026-05-12
G-100-24211-229103
CertifiedPrincipal Regulatory Affairs Specialist
2024-07-29 → 2025-11-25
G-100-24208-226743
CertifiedPrincipal Regulatory Affairs Specialist
2024-07-26 → 2025-11-24
G-100-24200-206609
CertifiedPrincipal Scientist, Injectables Analytical Research
2024-07-18 → 2025-11-21